Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
City of Hope, Duarte, California Kansas University Medical Center, Principal Investigator:, Westwood, Kansas Roswell Park Comprehensive Cancer Center, Buffalo, New York Oregon Health and Sciences University, Portland, Oregon University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington Taiwan
National Taiwan University Cancer Center, Taipei